Elite Pharmaceuticals Inc (ELTP)

[Trend-Setter]

It's a proposed treatment for addictive disorder with the focus on smoking tobacco.
"Considering the general role of dopamine transmission in substance use disorder, I expect that administration of PDE7 inhibitors would also reduce the motivation of other drugs of abuse, such as opioids, psychostimulants and alcohol.” --- This is just an expectation without any scientific proof ( human clinical trials ).

Now if you're thinking of incorporating it on an abuse deterrent drug formulation? Is it even feasible considering the resulting unknown side effects?